To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
352 Current news from the ressort manufacturingrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
BRAIN AG and CyPlus GmbH develop disruptive technologies
The bioeconomy company BRAIN AG and CyPlus GmbH have announced the development of an initial range of market-relevant products for the global mining industry. This work has been carried out as part of a multi-year collaboration between the companies in the area of biological ore processing to ...
Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to ...
Siemens becomes a preferred supplier for automation solutions
The Siemens technology group andSartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation. This agreement provides that Sartorius Stedim Biotech will preferably use Siemens automation ...
At Achema 2018 the Fraunhofer Institute for Chemical Technology will demonstrate the latest gen-eration of continuous reaction calorimeters. These permit rapid screening of thermokinetic data, making kinetic constants and safety-relevant data available in the early stages of process ...
PlasmidFactory GmbH & Co. KG announces that it has acquired new laboratory space for research and development as well as for the highly documented production of plasmid DNA, and has begun reconstructing and equipping the same. "New capabilities are the key to helping our customers move to ...
Toronto facility is one of the largest-ever investments by Sanofi in a single building
Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public ...
Manufacturing plant in Texas exeeds 25,000 square meters
Lonza today is opening the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies – the next era in medicine – and with the mission of enabling them to deliver these types of treatments to patients ...
New virus-free insect cell line
There are a multitude of challenges associated with the production of next-generation biopharmaceuticals and vaccines. The Austrian Centre of Industrial Biotechnology and the BOKU - University of Natural Resources and Life Sciences, Vienna together with the Boyce Thompson Institute (BTI) Ithaca, ...
Investment supports growing demand for biopharmaceutical manufacturing
Merck announced an additional investment of€40 million to build a robust manufacturing and distribution platform in Asia over a span of two years. This investment follows Merck’s November 2016 announcement of its €80 million Life Science investment in Nantong, China. “In biopharmaceutical ...
More than 15 years ago, scientists at the University of Missouri's Research Reactor (MURR®) identified promising properties of the radioisotope lutetium-177 (Lu-177), which can be used to treat cancer. It was recently announced that the U.S. Food and Drug Administration has approved a Lu-177 ...